Deerfield Management Company, L.P.'s Form 4 filing
Acutus Medical, Inc. (AFIB) · filed Jul 21, 2021
- Accession no.
- 0001193805-21-001059
- Filed
- Jul 21, 2021, 5:14 PM ET
- Trade date
- Jul 19, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $15.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Deerfield Management Company, L.P.CIK 0001009258 | Director, 10% Owner, Other: Director by Deputization |
| Deerfield Mgmt L.P.CIK 0001010823 | Director, 10% Owner, Other: Director by Deputization |
| Deerfield Partners, L.P.CIK 0001301041 | Director, 10% Owner, Other: Director by Deputization |
| Flynn James ECIK 0001352546 | Director, 10% Owner, Other: Director by Deputization |
| Deerfield Private Design Fund III, L.P.CIK 0001603333 | Director, 10% Owner, Other: Director by Deputization |
| Deerfield Mgmt III, L.P.CIK 0001610540 | Director, 10% Owner, Other: Director by Deputization |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2021 | Common Stock | PPurchaseAcquired | +390,836 | $14.00 | +$5,471,704 | 1,974,638 | Indirect | |
| Jul 19, 2021 | Common Stock | PPurchaseAcquired | +680,592 | $14.00 | +$9,528,288 | 3,438,589 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 3 with regard to Proteon Therapeutics, Inc. filed with the Securities and Exchange Commission on August 4, 2017 by Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., and James E. Flynn.